Pre Next

[1] ZHANG Meiling WANG Zhenzhi XIONG Kang LI XiongZHOU Feng,.Research Progress on Pathogenesis of Liver Injury inCOVID-2019 in Chinese and Western medicine [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2023, (03): 1-6. [doi: 10.13424/j.cnki.jsctcm.2023.03.001]

Copy

Research Progress on Pathogenesis of Liver Injury in COVID-2019 in Chinese and Western medicine

Journal of Shaanxi University of Traditional Chinese Medicine[ISSN: 2096-1340/ CN: 61-1501/R] Volumes & Issues: 2023 03 pagination: 1-6 Column: Publication date: 2023-05-31

Article number:: 2096-1340(2023)03-0001-06

Author(s):: ZHANG Meiling¹ WANG Zhenzhi¹ XIONG Kang¹ LI Xiong¹ZHOU Feng²; 1.Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712046,China;
2 Affiliated Hospital of Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712046,China

Keywords:: Key words： Coronavirus; COVID-19; Liver injury; Chinese medicine; Western medicine; Pathogenesis

ZTFLH:: R245.2

DOI:: 10.13424/j.cnki.jsctcm.2023.03.001

Code:: A

Abstract:: Abstract： In the context of COVID-2019,hepatotoxicity is not uncommon.It can be seen from chemical changes without liver disease to progressive decompensation with underlying liver disease.At present,the pathogenesis of COVID-19 liver injury is not clear.From the perspective of modern medicine,there are direct viruses,cytokine storms,drug-related,hypoxemia,coagulation mechanism disorders,Renin Angiotensin System (RAS),etc.Traditional medicine believes that it may be related to the abnormal rise and fall of Qi,the five elements riding and aggressive,and the interconnection of meridians.In addition,transport and storage disorders,and Yin Yang imbalance may also be involved in liver injury,or there may be complex mechanisms of interaction among various factors.In the future research,we should continue to explore the mechanism of action of COVID-19 from the perspective of modern medicine and traditional Chinese medicine theory,look for different ways of signal transmission and biochemical effects,and provide scientific and effective therapeutic evidence for further improving clinical application.

References:

［1］Yuki K,Fujiogi M,Koutsogiannaki S.COVID-2019 pathophysiology:A review［J］.Clinical immunology,2020,215:108427.
［2］Araf Y,Faruqui NA,Anwar S,et al.SARS-CoV-2:a new dimension to our understanding of coronaviruses［J］.International Microbiology,2021,24(1):19-24.
［3］Li S,Tang Z,Li Z,et al.Searching therapeutic strategy of new coronavirus pneumonia from angiotensinconverting enzyme 2:the target of COVID-19 and SARSCoV ［J］.European Journal of Clinical Microbiology & Infectious Diseases,2020,39(6):1021-1026.
［4］Ciotti M,Ciccozzi M,Terrinoni A,et al.The COVID-2019 pandemic［J］.Critical Reviews in Clinical Laboratory Sciences,（2020）57：6，365-388.
［5］Chai X,Hu L,Zhang Y,et al.Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection［J］.biorxiv,2020.
［6］Lei F,Liu YM,Zhou F,et al.Longitudinal association between markers of liver injury and mortality in COVID19 in China［J］.Hepatology,2020,72(2):389-398.
［7］褚扬,周王谊,吴江,等.新型冠状病毒肺炎治疗中应关注肝损伤及防治中药概述［J］.世界中医药,2020,15(2):129-133.
［8］Xu L,Liu J,Lu M,et al.Liver injury during highly pathogenic human coronavirus infections［J］.Liverinternational,2020,40(5):998-1004.
［9］Zhong P,Xu J,Yang D,et al.COVID-2019associated gastrointestinal and liver injury:clinical features and potential mechanisms［J］.Signal Transduction and Targeted Therapy,2020,5(1):1-8.
［10］Chu H,Bai T,Chen L,et al.Multicenter analysis of liver injury patterns and mortality in COVID-19 ［J］.Frontiers in medicine,2020,7:584342.
［11］Lei HY,Ding YH,Nie K,et al.Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver［J］.Biomedicine & Pharmacotherapy,2021,133:111064.
［12］Fan Z,Chen L,Li J,et al.Clinical features of COVID-2019related liver functional abnormality［J］.Clinical Gastroenterology and Hepatology,2020,18(7):1561-1566.
［13］Wang Y,Liu S,Liu H,et al.SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID2019［J］.Journal of hepatology,2020,73(4):807-816.
［14］Chau TN,Lee KC,Yao H,et al.SARSassociated viral hepatitis caused by a novel coronavirus:report of three cases［J］.Hepatology,2004,39(2):302-310.
［15］Gao RY,Wang M,Liu Q,et al.Hypoxia-Inducible Factor-2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin-6［J］.Hepatology,2020,71(6):2105-2117.
［16］Yan M,Huo Y,Yin S,et al.Mechanisms of acetaminopheninduced liver injury and its implications for therapeutic interventions［J］.Redox biology,2018,17:274-283.
［17］Zha BS,Wan X,Zhang X,et al.HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes［J］.PloS one,2013,8(3):e59514.
［18］Cai Q,Huang D,Yu H,et al.COVID2019:abnormal liver function tests［J］.Journal of hepatology,2020,73(3):566-574.
［19］Ali N.Relationship between COVID2019 infection and liver injury:A review of recent data［J］.Frontiers in Medicine,2020,7:458.
［20］李晓骄阳,李雅静,葛俊德,等.注重新型冠状病毒肺炎(COVID2019)治疗中药物性肝损伤的预警与保护［J］.中草药,2020,51(4):851-859.
［21］CoronavirusCOVID19;Investigators at Shanghai Public Health Clinical Center Target COVID-19 (COVID-19 with Different Severity:A Multi-center Study of Clinical Features)［J］.Medical Letter on the CDC & FDA,2020.
［22］Effenberger M,Grander C,Grabherr F,et al.Systemic inflammation as fuel for acute liver injury in COVID-2019［J］.Digestive and Liver Disease,2021,53(2):158-165.
［23］Liu J,Li S,Liu J,et al.Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARSCoV2 infected patients［J］.Ebio Medicine,2020,55:102763.
［24］Feng G,Zheng KI,Yan QQ,et al.COVID2019 and liver dysfunction:current insights and emergent therapeutic strategies［J］.Journal of clinical and translational hepatology,2020,8(1):18.
［25］胡水清,张泰昌,张玫.低氧血症与SARS肝损伤的关系及还原型谷胱甘肽对肝损伤的疗效［J］.中国新药杂志,2004(11):1046-1048.
［26］Zhang Y,He L,Chen H,et al.Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients:Retrospective analysis［J］.International Journal of Laboratory Hematology,2020,42(6):766-772.
［27］张华军,刘婷婷,钱秀刚,等.浅论《瘟疫论》对新型冠状病毒肺炎防治的指导意义［J］.四川中医,2021,39(9):5-8.
［28］姜慧,齐向华,滕晶.吴又可《瘟疫论》理论辨析新型冠状病毒肺炎［J］.四川中医,2020,38(3):12-14.
［29］马丹,张文风.中医疫病发病与气候因素相关性探究［J］.长春中医药大学学报,2021,37(1):1-5.
［30］陈泽奇,陈国林,潘其民,等.中医肝病与西医肝胆疾患关系的探讨［J］.新中医,1990(9):12-13.
［31］尹常健.现代肝病中医临证指要［J］.山东中医杂志,2022,41(1):7-12,6.
［32］刘兰军,孙爱云.论中医肝与肺的关系［J］.中医学报,2015,30(12):1767-1768,1771.
［33］吴勉华，王新月.中医内科学［M］.北京:中国中医药出版社,2012:54-58.
［34］陈星,刘清娥.论中医肝的实质与功能［J］.陕西中医学院学报,2015,38(5):5-7.
［35］郝建梅,赵锋,刘素香,等.杨震教授从“一气周流”理论辨治新冠肺炎恢复阶段［J］.陕西中医药大学学报,2020,43(4):40-42,67.
［36］谢小峥,杨梦蝶,陈健,等.中医肝藏功能及其脏腑关系的研究进展［J］.世界科学技术中医药现代化,2018,20(12):2185-2190.
［37］马雪玲,王田,刘婧玮,等.从高血压肝火亢盛证的应激变化探讨肝主疏泄的生物学基础［J］.世界中医药,2017,12(12):3063-3067.
［38］Silva GM,Frana Falco MS,Calzerra NT M,et al.Role of reninangiotensin system components in atherosclerosis:Focus on AngⅡ,ACE2,and Ang1-7［J］.Frontiers in Physiology,2020,11:1067.
［39］LopesPacheco M,Silva P L,Cruz FF,et al.Pathogenesis of multiple organ injury in COVID-2019 and potential therapeutic strategies［J］.Frontiers in physiology,2021,12:29.
［40］郑洪新.中医基础理论［M］北京:中国中医药出版社,2016.
［41］Wang T,Du Z,Zhu F,et al.Comorbidities and multiorgan injuries in the treatment of COVID-2019［J］.The Lancet,2020,395(10228):e52.
［42］刘臻,朱虹,张铭倩,等.“肝肺气机升降循环”理论治法探讨［J］.山东中医杂志,2018,37(8):631-633.
［43］陈志惠,张世荣,孙文静,等.非酒精性脂肪性肝病患者肺功能变化临床分析［J］.临床肝胆病杂志,2018,34(4):825-828.
［44］赵鑫,杨玉松,吕文良,等.从肺论治酒精性肝病［J］.中医学报,2020,35(10):2068-2071.
［45］杨曼芩,范伏元.浅析从肝治肺［J］.中医药临床杂志,2021,33(4):660-663.
［46］夏露,吴欢,刘平,等.中西医结合治疗新型冠状病毒肺炎100例疗效及肝损伤情况分析［J］.上海中医药杂志,2020,54(7):23-28.
［47］陈仁寿.中医药辨治疫病的历史回顾与现代启示［J］.中国合理用药探索,2020,17(2):8-13.

Memo

基金项目：国家自然科学基金面上项目（81873387,82074552）；国家中医药创新骨干人才项目（〔2019〕128号）；陕西中医药大学培养计划项目（2017SZKY-018）；陕西省咸阳市中青年科技领军人才培育项目（2019k01-52）

Last Update: 2023-05-19